Weiss Multi-Strategy Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-60,000	Closed	-$8.74M	–	830
2022 Q2	$8.74M	Sell	60,000 -5,725	-9%	-$731K	0.26%	125
2022 Q1	$7.79M	Sell	65,725 -6,920	-10%	-$863K	0.18%	197
2021 Q4	$10M	Sell	72,645 -2,355	-3%	-$299K	0.23%	128
2021 Q3	$10.4M	Sell	75,000 -16,372	-18%	-$2.04M	0.22%	139
2021 Q2	$8.87M	Buy	91,372 +2,661	+3%	+$216K	0.2%	163
2021 Q1	$6.06M	Buy	88,711 +48,515	+121%	+$3.92M	0.13%	224
2020 Q4	$3.44M	Sell	40,196 -42,804	-52%	-$3.63M	0.07%	326
2020 Q3	$5.4M	Sell	83,000 -18	-0%	-$1.18K	0.14%	204
2020 Q2	$6.07M	Sell	83,018 -2,819	-3%	-$150K	0.17%	184
2020 Q1	$2.92M	Sell	85,837 -9,163	-10%	-$419K	0.11%	218
2019 Q4	$5.17M	Sell	95,000 -10,000	-10%	-$495K	0.08%	301
2019 Q3	$4.38M	Sell	105,000 -21,000	-17%	-$887K	0.09%	273
2019 Q2	$5.52M	Buy	126,000 +116,000	+1,160%	+$6.54M	0.15%	159
2019 Q1	$515K	Sell	10,000 -1,000	-9%	-$43.2K	0.01%	435
2018 Q4	$407K	Sell	11,000 -4,000	-27%	-$144K	0.02%	365
2018 Q3	$563K	Buy	15,000 +7,000	+88%	+$257K	0.01%	434
2018 Q2	$316K	Buy	+8,000	New	+$254K	0.01%	510

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BHVN Position: Q3 2022 in Review

Weiss Multi-Strategy Advisers sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 60,000 shares — an estimated $8.74M sold.

Weiss Multi-Strategy Advisers first reported a position in BHVN in Q2 2018 and held it in 17 quarters. The position peaked at $10.4M in Q3 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Weiss Multi-Strategy Advisers reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 60,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $8.74M.
Weiss Multi-Strategy Advisers first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 17 quarters.
Weiss Multi-Strategy Advisers's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10.4M in Q3 2021.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.